Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Accumulated Expenses (2019 - 2025)

Historic Accumulated Expenses for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $10.7 million.

  • Outset Medical's Accumulated Expenses fell 3618.1% to $10.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.7 million, marking a year-over-year decrease of 3618.1%. This contributed to the annual value of $10.7 million for FY2025, which is 3618.1% down from last year.
  • Outset Medical's Accumulated Expenses amounted to $10.7 million in Q4 2025, which was down 3618.1% from $10.9 million recorded in Q3 2025.
  • Outset Medical's 5-year Accumulated Expenses high stood at $23.3 million for Q2 2022, and its period low was $3.7 million during Q4 2021.
  • Its 5-year average for Accumulated Expenses is $15.1 million, with a median of $15.0 million in 2021.
  • In the last 5 years, Outset Medical's Accumulated Expenses skyrocketed by 50964.64% in 2021 and then plummeted by 4216.03% in 2025.
  • Outset Medical's Accumulated Expenses (Quarter) stood at $3.7 million in 2021, then soared by 480.97% to $21.5 million in 2022, then dropped by 11.68% to $19.0 million in 2023, then fell by 11.49% to $16.8 million in 2024, then tumbled by 36.18% to $10.7 million in 2025.
  • Its Accumulated Expenses stands at $10.7 million for Q4 2025, versus $10.9 million for Q3 2025 and $9.8 million for Q2 2025.